Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Mougel

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Oncotarget|June 23, 2018
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitorsMeriem Sarah Mekki, Alexandra Mougel, Audrey Vinchent, et al.
Plos One|May 3, 2013
LMP1-induced cell death may contribute to the emergency of its oncogenic propertyGuillaume Brocqueville, Papa Alioune Ndour, Tan-Sothéa Ouk, et al.
Journal of Virology|January 20, 2012
Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cellsPapa Alioune Ndour, Guillaume Brocqueville, Tan-Sothéa Ouk, et al.
International Journal of Molecular Sciences|December 23, 2022
Macrophage-Colony-Stimulating Factor Receptor Enhances Prostate Cancer Cell Growth and Aggressiveness In Vitro and In Vivo and Increases Osteopontin ExpressionAlexandra Mougel, Eric Adriaenssens, Boris Guyot, et al.
Chemical Science|July 19, 2017
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent <i>in vivo</i> MET receptor agonistClaire Simonneau, Bérénice Leclercq, Alexandra Mougel, et al.
Life Science Alliance|July 29, 2022
Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonistGiovanni de Nola, Bérénice Leclercq, Alexandra Mougel, et al.
Journal of Virology|July 15, 2006
Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kappaB and JNK signaling pathwaysGautier Goormachtigh, Tan-Sothéa Ouk, Alexandra Mougel, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncotarget|June 23, 2018
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitorsMeriem Sarah Mekki, Alexandra Mougel, Audrey Vinchent, et al.
Plos One|May 3, 2013
LMP1-induced cell death may contribute to the emergency of its oncogenic propertyGuillaume Brocqueville, Papa Alioune Ndour, Tan-Sothéa Ouk, et al.
Journal of Virology|January 20, 2012
Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cellsPapa Alioune Ndour, Guillaume Brocqueville, Tan-Sothéa Ouk, et al.
International Journal of Molecular Sciences|December 23, 2022
Macrophage-Colony-Stimulating Factor Receptor Enhances Prostate Cancer Cell Growth and Aggressiveness In Vitro and In Vivo and Increases Osteopontin ExpressionAlexandra Mougel, Eric Adriaenssens, Boris Guyot, et al.
Chemical Science|July 19, 2017
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent <i>in vivo</i> MET receptor agonistClaire Simonneau, Bérénice Leclercq, Alexandra Mougel, et al.
Life Science Alliance|July 29, 2022
Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonistGiovanni de Nola, Bérénice Leclercq, Alexandra Mougel, et al.
Journal of Virology|July 15, 2006
Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kappaB and JNK signaling pathwaysGautier Goormachtigh, Tan-Sothéa Ouk, Alexandra Mougel, et al.
Pageof 2